{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:20:38Z","timestamp":1790709638667,"version":"4.1.0"},"reference-count":23,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,9]]},"abstract":"<jats:p><jats:italic>Leishmania<\/jats:italic> sp<jats:italic>.<\/jats:italic> is an intracellular parasite that causes a variable degree of clinical manifestations, especially in the skin. We present the case of a 38-year-old male with a chronic history of mucocutaneous disease present since childhood that generated deformity, loss of cartilage in the ears and nose, and scarring that limited his range of motion. The parasite was identified as <jats:italic>L. mexicana mexicana<\/jats:italic>. The patient was treated with a 3-month course of oral miltefosine with overwhelming results.<\/jats:p>","DOI":"10.4269\/ajtmh.2012.11-0592","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T01:49:57Z","timestamp":1355449797000},"page":"153-156","source":"Crossref","is-referenced-by-count":13,"title":["Transient Success Using Prolonged Treatment with Miltefosine for a Patient with Diffuse Cutaneous Leishmaniasis Infected with Leishmania mexicana mexicana"],"prefix":"10.4269","volume":"88","author":[{"given":"Alejandro","family":"Ordaz-Farias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fania Z.","family":"Mu\u00f1oz-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah K.","family":"Sevilla-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Arana-Guajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ocampo-Candiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Trevi\u00f1o-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Camacho-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"R1","series-title":"Parassitologia","first-page":"211","article-title":"Prevention and control of leishmaniasis vectors: current approaches","volume":"46","author":"Maroli","year":"2004"},{"key":"R2","series-title":"Control of Leishmaniases. Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases","author":"World Health Organization"},{"key":"R3","series-title":"Expert Rev Anti Infect Ther","first-page":"919","article-title":"Current diagnosis and treatment of visceral leishmaniasis","volume":"8","author":"Mondal","year":"2010"},{"key":"R4","series-title":"Curr Opin Chem Biol","first-page":"447","article-title":"New antileishmanial candidates and lead compounds","volume":"14","author":"Richard","year":"2010"},{"key":"R5","series-title":"An Bras Dermatol","first-page":"497","article-title":"Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: asystematic literature review","volume":"86","author":"Almeida","year":"2011"},{"key":"R6","series-title":"Br J Dermatol","first-page":"1328","article-title":"Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses","volume":"156","author":"Zerpa","year":"2007"},{"key":"R7","series-title":"J Infect Dis","first-page":"1829","article-title":"Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil","volume":"186","author":"Turetz","year":"2002"},{"key":"R8","series-title":"Parasite Immunol","first-page":"671","article-title":"CD8 cytotoxic T cells in cutaneous leishmaniasis","volume":"29","author":"Ruiz","year":"2007"},{"key":"R9","series-title":"PLoS Negl Trop Dis","first-page":"e871","article-title":"CD8 cells of patients with diffuse cutaneous leishmaniasis display funconal exhaustion: the latteris reversed, in vitro, by TLR2 agonists","volume":"4","author":"Hern\u00e1ndez-Ruiz","year":"2010"},{"key":"R10","series-title":"Rev Soc Bras Med Trop","first-page":"14","article-title":"Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment","volume":"39","author":"Mayrink","year":"2006"},{"key":"R11","series-title":"Am J Trop Med Hyg","first-page":"378","article-title":"Increase of NK cells and proinflammatory monocytes are associated with the clinical improvementof diffuse cutaneous leishmaniasis after immunochemotherapy with BCG\/Leishmania antigens","volume":"81","author":"Pereira","year":"2009"},{"key":"R12","series-title":"Immunotherapy.","first-page":"765","article-title":"Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature","volume":"1","author":"Okwor","year":"2009"},{"key":"R13","series-title":"Arch Dermatol","first-page":"301","article-title":"An Autochthonous Case in Texas and the Mexican States of Tamaulipas and Nuevo Leon","volume":"97","author":"Simpson","year":"1968"},{"key":"R14","series-title":"Vet Pathol","first-page":"1076","article-title":"Eight cases of feline cutaneous leishmaniasis in Texas","volume":"47","author":"Trainor","year":"2010"},{"key":"R15","series-title":"J Am Acad Dermatol","first-page":"508","article-title":"Cutaneous leishmaniasis in Texas","volume":"62","author":"McHugh","year":"2010"},{"key":"R16","series-title":"J Am Acad Dermatol","first-page":"650","article-title":"Cutaneous leishmaniasis in Texas: a northern spread of endemic areas","volume":"58","author":"Wright","year":"2008"},{"key":"R17","series-title":"J Vector Borne Dis","first-page":"287","article-title":"A comparative study between the efficacy of systemic meglumineantimoniate therapy with standard or low dose plus omeprazole in the treatment of cutaneous leishmaniasis","volume":"45","author":"Nilforoushzadeh","year":"2008"},{"key":"R18","series-title":"Lancet Infect Dis","first-page":"184","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"Van Griensven","year":"2010"},{"key":"R19","series-title":"Acta Trop","first-page":"188","article-title":"Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv","volume":"119","author":"Shakya","year":"2011"},{"key":"R20","series-title":"Arch Iran Med","first-page":"238","article-title":"Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumineantimoniate, imiquimod or combination therapy","volume":"14","author":"Shamsi Meymandi","year":"2011"},{"key":"R21","series-title":"Eur J Dermatol","first-page":"513","article-title":"Evaluation of meglumineantimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis","volume":"17","author":"Kashani","year":"2007"},{"key":"R22","series-title":"Clin Infect Dis","first-page":"350","article-title":"Treatment of Bolivian mucosal leishmaniasis with miltefosine","volume":"44","author":"Soto","year":"2007"},{"key":"R23","series-title":"Am J Trop Med Hyg","first-page":"1074","article-title":"Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment","volume":"75","author":"Calvopina","year":"2006"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/88\/1\/article-p153.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/88\/1\/article-p153.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/88\/1\/article-p153.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T18:52:48Z","timestamp":1723056768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/88\/1\/article-p153.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,9]]},"references-count":23,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.2012.11-0592","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,9]]}}}